Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy.
about
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Five-year efficacy and safety ...... iously failed LAM/ADV therapy.
@en
type
label
Five-year efficacy and safety ...... iously failed LAM/ADV therapy.
@en
prefLabel
Five-year efficacy and safety ...... iously failed LAM/ADV therapy.
@en
P2093
P2860
P356
P1433
P1476
Five-year efficacy and safety ...... iously failed LAM/ADV therapy.
@en
P2093
Alexander Thompson
Jacob George
Kaye Marion
Paul Desmond
Peter Angus
Scott Bowden
Scott Patterson
Simone Strasser
P2860
P304
P356
10.1111/LIV.13331
P577
2016-11-29T00:00:00Z